Palisades Therapeutics Drug Platform Demonstrates Reduction in Neuroinflammation Across Three Species
FDA IND assigned for Neurodegeneration to Palisades Therapeutics CLIFFSIDE PARK, NEW JERSEY, USA, January 18, 2022 /EINPresswire.com/ -- Reduction in neuroinflammation demonstrated in three species –mice, rats and hamsters- all consistent …